In summary, the present study demonstrates that IGF2BP3, an RNA-binding protein, is upregulated in animal models and patients with CKD and critically involved in kidney fibrogenesis by activating β-catenin signaling. This evidence concerns the gene IGF2BP3 and chronic kidney disease.